Alyftrek 20 mg (Tezacaftor TABLET) 20 MG

Alyftrek 20 mg tablets contain tezacaftor, a medication used to treat certain conditions related to cystic fibrosis. This oral medication is designed to improve lung function and overall health in patients with specific genetic mutations.

Strength

20 MG

Manufacturer / TM Owner

VERTEX PHARMACEUTICALS (CANADA) INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Alyftrek 20 mg tablets are primarily used in the management of cystic fibrosis. Tezacaftor works by enhancing the function of a protein involved in chloride transport, which is often defective in individuals with cystic fibrosis. This can help improve lung function and reduce the frequency of pulmonary exacerbations. The medication is typically prescribed as part of a combination therapy to address the underlying causes of the disease.

Side Effects

Common effects of Alyftrek 20 mg tablets may include headaches, fatigue, and gastrointestinal issues such as nausea or diarrhea. Some individuals may also experience dizziness or changes in liver function. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Alyftrek 20 mg tablets should be handled with care, especially for individuals with liver conditions or a history of allergic reactions to similar medications. Regular monitoring of liver function is recommended. The medication should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Avoid Interactions

Alyftrek 20 mg tablets may interact with certain medications, including strong CYP3A inducers or inhibitors, which can affect the metabolism of tezacaftor. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Alyftrek 20 mg tablets are used to treat cystic fibrosis in patients with specific genetic mutations. They help improve lung function and overall health.

Alyftrek 20 mg tablets are taken orally, typically once daily. Follow the instructions provided by your healthcare provider for the best results.

Common side effects may include headaches, fatigue, nausea, diarrhea, and dizziness. Consult your healthcare provider if these effects are severe or persistent.

Alyftrek 20 mg may interact with certain medications, especially those that affect liver enzymes. Always inform your healthcare provider about all medications you are taking.

Alyftrek 20 mg is designed for long-term use in managing cystic fibrosis. Regular monitoring by a healthcare provider is recommended to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.